BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 776312)

  • 1. A controlled trial of phenothiazine withdrawal in chronic schizophrenic patients.
    Andrews P; Hall JN; Snaith RP
    Br J Psychiatry; 1976 May; 128():451-5. PubMed ID: 776312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premorbid asocial adjustment and response to phenothiazine treatment among schizophrenic inpatients.
    Klein DF; Rosen B
    Arch Gen Psychiatry; 1973 Oct; 29(4):480-5. PubMed ID: 4583948
    [No Abstract]   [Full Text] [Related]  

  • 3. A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients.
    Shopsin B; Pearson E; Gershon S; Collins P
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):739-48. PubMed ID: 4629112
    [No Abstract]   [Full Text] [Related]  

  • 4. Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
    Jus A; Pineau R; Jus K; Villeneuve A; Gautier J; Pires P; Drolet A; Cote M; Villeneuve R
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1041-58. PubMed ID: 4215617
    [No Abstract]   [Full Text] [Related]  

  • 5. Relapse in chronic schizophrenics following abrupt withdrawal of tranquillizing medication.
    Prien RF; Cole JO; Belkin NF
    Br J Psychiatry; 1969 Jun; 115(523):679-86. PubMed ID: 5806858
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract]   [Full Text] [Related]  

  • 7. A study of the withdrawal of chlorpromazine or trifluoperazine in chronic schizophrenia.
    Morton MR
    Am J Psychiatry; 1968 May; 124(11):1585-8. PubMed ID: 4869439
    [No Abstract]   [Full Text] [Related]  

  • 8. Alpha-methyldopa-chlorpromazine combination in schizophrenic patients.
    Chouinard G; Annable L
    Neuropsychobiology; 1976; 2(2-3):118-26. PubMed ID: 796755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immediate effects of chlorpromazine in newly admitted schizophrenic patients.
    Hamill WT; Fontana AF
    Am J Psychiatry; 1975 Oct; 132(10):1023-6. PubMed ID: 1101707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia.
    Knight RG; Harrison A
    N Z Med J; 1979 Apr; 89(634):302-4. PubMed ID: 377155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind trial of fluphenazine decanoate.
    Curry SH; Adamson L
    Lancet; 1972 Sep; 2(7776):543-4. PubMed ID: 4115602
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential effects of abrupt versus gradual withdrawal of chlorpromazine in hospitalized chronic schizophrenic patients.
    Greenberg LM; Roth S
    Am J Psychiatry; 1966 Aug; 123(2):221-6. PubMed ID: 5947494
    [No Abstract]   [Full Text] [Related]  

  • 13. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
    Wilson LG; Roberts RW; Gerber CJ; Johnson MH
    J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha methyldopa-chlorpromazine interaction in schizophrenic patients.
    Chouinard G; Pinard G; Prenoveau Y; Tetreault L
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):60-72. PubMed ID: 4632508
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind comparison of pimozide and chlorpromazine in the maintenance care of chronic schizophrenic outpatients.
    Kolivakis T; Azim H; Kingstone E
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):998-1004. PubMed ID: 4214674
    [No Abstract]   [Full Text] [Related]  

  • 16. The evaluation of chlorpromazine therapy in chronic schizophrenic women. A replicated experiment.
    Ragland R; Clark ML; Ray TS; Paredes A; Costiloe JP; Segal B; Wolf S
    J Chronic Dis; 1968 Oct; 21(6):445-60. PubMed ID: 4879902
    [No Abstract]   [Full Text] [Related]  

  • 17. Chlorpromazine and the untreated chronic schizophrenic: a long-term trial.
    Letemendia FJ; Harris AD
    Br J Psychiatry; 1967 Sep; 113(502):950-8. PubMed ID: 4862704
    [No Abstract]   [Full Text] [Related]  

  • 18. Trial of maintenance therapy in schizophrenia.
    Leff JP; Wing JK
    Br Med J; 1971 Sep; 3(5775):599-604. PubMed ID: 4936538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective drug action related to chronic schizophrenic subtype. (A comparative study of carphenazine, chlorpromazine, and trifluoperazine).
    Platz AR; Klett CJ; Caffey EM
    Dis Nerv Syst; 1967 Sep; 28(9):601-5. PubMed ID: 4861216
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolixin enanthate and thorazine-stelazine regimens in the treatment of schizophrenic patients. An experimental evaluation.
    DeWolfe AS; Barrell RP; London L; Spaner FE
    Psychosomatics; 1971; 12(3):186-90. PubMed ID: 4950862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.